Group B Streptococcus Response After Probiotic Exposure
Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
This is an open-label randomized control trial and feasibility study designed to determine
the feasibility of a larger RCT in our setting that would examine prenatal probiotic use in
Group B Strep (GBS) positive pregnant women at term. Investigators hope to address the
question of whether prenatal oral probiotic use, taken by healthy low risk GBS positive women
from approximately 37 weeks gestation until the time of birth, will reduce the number of
women who test positive for GBS at the time of admission to Labor and Delivery (L&D).